CDC7 and frontotemporal dementia: The relevant role of targeting CDC7 as a therapy for ALS and FTD has been recently reported with brain permeable inhibitors11,12, which points to the value of CDC7 inhibitors for the therapy of these devastating neurodegenerative diseases.